ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
会议论文

A phase Ib/II study of SHR-1701 (a bifunctional anti-PD-L1/ TGF-bRII agent) in combination with bevacizumab (BEV) in patients with advanced solid tumors

Xu, R-H.; Huiyan, L.; Zhao, H.; Wei, W.; Ma, D.; Yin, X.; Ni, Y.; Wang, Y.; Zhang, Y.; Zhou, J.; Pan, H.; Niu, Z.; Zhang, J.; Ren, H.; Kang, M.; Jia, W.; Gu, S.; Liu, P.; Zhang, Z.; Wang, S.山东大学; 上海交通大学; 哈尔滨医科大学; 浙江大学; 郑州大学; 中山大学; 1; i
Annual Meeting of the European-Society-for-Medical-Oncology (ESMO)2023-10DOI: 10.1016/j.annonc.2023.09.2165
8阅读
引用收藏
分享
相关
加载中…
  • A phase I study of SHR-1701, a bifunctional fusion protein targeting PD-L1 and TGF-b, in patients with advanced nonsmall cell lung cancer (NSCLC)
    Feng, J.; Shi, M.; Chen, J.; Li, K.; Li, X.; Sun, M.; Li, B.; Wen, G.; Fang, Y.; Min, X.; Lin, L.; Liu, Y.; Wang, Q.; Lu, S.; Zhu, B.; Shi, Y-K.; Yu, H.; Peng, Y.; Liang, F.; Liu, P.Annual Meeting of the European-Society-for-Medical-Oncology (ESMO), SINGAPORE, 2023-12-01 To 2023-12-03.
  • Phase I/IIa study of PM8001, a bifunctional fusion protein targeting PD-L1 and TGF-?, in patients with advanced tumors
    Guo, Ye; Liu, Baogang; Lv, Dongqing; Cheng, Ying; Zhou, Tong; Zhong, Yahua; Hu, Changlu; Chen, Gang; Wu, Xiaohua; Yin, Yongmei; Wu, Lihua; Chen, Zhendong; Luo, Hong; Zhou, Xiaohong; Qin, Yanru; Yang, Yuxing; Luo, Suxia; Ma, Yanjie; Li, Yalin; Hu, GuoqiangAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO), ELECTR NETWORK, 2022-06-03 To 2022-06-07.被引 5
  • SHR-1701 in combination with BP102 and XELOX as first-line (1L) treatment for patients (pts) with unresectable metastatic colorectal cancer (mCRC): Data from a phase II/III study
    Xu, R-H.; Qiu, M.; Bai, Y.; Wang, J.; Gu, K.; Yang, M.; He, Y.; Yi, C.; Jin, Y.; Liu, B.; Wang, F.; Huang, C.; Jiang, Y.Annual Meeting of the European-Society-for-Medical-Oncology (ESMO), Barcelona, SPAIN, 2023-10-20 To 2023-10-24.
查看全部 →

会议信息

会议名称
Annual Meeting of the European-Society-for-Medical-Oncology (ESMO)
会议日期
2023-10-20 至 2023-10-24
论文集名
ANNALS OF ONCOLOGY
发表日期
2023-10
起止页码
S624-S624
DOI
10.1016/j.annonc.2023.09.2165
资助标注
Jiangsu Hengrui Pharmaceuticals
收录
ISTP · SCIE

作者

  • X

    Xu, R-H. (第一作者)

    sun yat sen univ

  • H

    Huiyan, L.

    sun yat sen univ

查看全部 20 位作者收起作者
  • Z

    Zhao, H.

    i · sun yat sen univ

  • W

    Wei, W.

    sun yat sen univ

  • M

    Ma, D.

    zhengzhou univ

  • Y

    Yin, X.

    hunan canc hosp

  • N

    Ni, Y.

    shanxi prov hosp

  • W

    Wang, Y.

    shanxi prov canc hosp

  • Z

    Zhang, Y.

    harbin med univ

  • Z

    Zhou, J.

    sichuan canc hosp

  • P

    Pan, H.

    zhejiang univ

  • N

    Niu, Z.

    shandong univ

  • Z

    Zhang, J.

    ruijin hosp · shanghai jiao tong univ

  • R

    Ren, H.

    2 · chongqing med univ

  • K

    Kang, M.

    guilin med univ

  • J

    Jia, W.

    1 · anhui prov hosp · ustc

  • G

    Gu, S.

    hunan canc hosp

  • L

    Liu, P.

  • Z

    Zhang, Z.

  • W

    Wang, S.

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417